Medistim ASA (0OCD.L)
- Previous Close
218.02 - Open
175.02 - Bid --
- Ask --
- Day's Range
175.02 - 175.02 - 52 Week Range
175.02 - 300.00 - Volume
12 - Avg. Volume
98 - Market Cap (intraday)
33.851M - Beta (5Y Monthly) --
- PE Ratio (TTM)
0.34 - EPS (TTM)
5.08 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Europe, Asia, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which is designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation of fragile or calcified vessels; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.
www.medistim.com150
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Related News
Performance Overview: 0OCD.L
Trailing total returns as of 4/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0OCD.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0OCD.L
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
19.51%
Return on Assets (ttm)
15.82%
Return on Equity (ttm)
24.73%
Revenue (ttm)
525.64M
Net Income Avi to Common (ttm)
102.54M
Diluted EPS (ttm)
5.08
Balance Sheet and Cash Flow
Total Cash (mrq)
170.26M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
82.18M
Company Insights: 0OCD.L
0OCD.L does not have Company Insights